• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

阿尔茨海默病的血管 - 免疫假说

The Vascular-Immune Hypothesis of Alzheimer's Disease.

作者信息

Mehta Rashi I, Mehta Rupal I

机构信息

Department of Neuroradiology, Rockefeller Neuroscience Institute, West Virginia University, Morgantown, WV 26506, USA.

Department of Neuroscience, Rockefeller Neuroscience Institute, West Virginia University, Morgantown, WV 26506, USA.

出版信息

Biomedicines. 2023 Jan 30;11(2):408. doi: 10.3390/biomedicines11020408.

DOI:10.3390/biomedicines11020408
PMID:36830944
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9953491/
Abstract

Alzheimer's disease (AD) is a devastating and irreversible neurodegenerative disorder with unknown etiology. While its cause is unclear, a number of theories have been proposed to explain the pathogenesis of AD. In large part, these have centered around potential causes for intracerebral accumulation of beta-amyloid (βA) and tau aggregates. Yet, persons with AD dementia often exhibit autopsy evidence of mixed brain pathologies including a myriad of vascular changes, vascular brain injuries, complex brain inflammation, and mixed protein inclusions in addition to hallmark neuropathologic lesions of AD, namely insoluble βA plaques and neurofibrillary tangles (NFTs). Epidemiological data demonstrate that overlapping lesions diminish the βA plaque and NFT threshold necessary to precipitate clinical dementia. Moreover, a subset of persons who exhibit AD pathology remain resilient to disease while other persons with clinically-defined AD dementia do not exhibit AD-defining neuropathologic lesions. It is increasingly recognized that AD is a pathologically heterogeneous and biologically multifactorial disease with uncharacterized biologic phenomena involved in its genesis and progression. Here, we review the literature with regard to neuropathologic criteria and incipient AD changes, and discuss converging concepts regarding vascular and immune factors in AD.

摘要

阿尔茨海默病(AD)是一种病因不明的毁灭性且不可逆的神经退行性疾病。尽管其病因尚不清楚,但已提出了一些理论来解释AD的发病机制。在很大程度上,这些理论都围绕着β-淀粉样蛋白(βA)和tau蛋白聚集体在脑内积累的潜在原因。然而,患有AD痴呆症的人尸检时往往显示出混合性脑病理证据,除了AD的标志性神经病理病变,即不溶性βA斑块和神经原纤维缠结(NFTs)外,还包括大量血管变化、血管性脑损伤、复杂的脑炎症和混合性蛋白质包涵体。流行病学数据表明,重叠性病变会降低引发临床痴呆所需的βA斑块和NFT阈值。此外,一部分表现出AD病理特征的人对疾病具有抵抗力,而其他临床诊断为AD痴呆症的人却没有表现出AD特征性神经病理病变。人们越来越认识到,AD是一种病理异质性和生物学多因素疾病,其发生和发展涉及尚未明确的生物学现象。在此,我们回顾了有关神经病理学标准和早期AD变化的文献,并讨论了关于AD中血管和免疫因素的趋同概念。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3347/9953491/5fda420ce241/biomedicines-11-00408-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3347/9953491/ed6d9d5b01c8/biomedicines-11-00408-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3347/9953491/905ec4104d13/biomedicines-11-00408-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3347/9953491/5fda420ce241/biomedicines-11-00408-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3347/9953491/ed6d9d5b01c8/biomedicines-11-00408-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3347/9953491/905ec4104d13/biomedicines-11-00408-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3347/9953491/5fda420ce241/biomedicines-11-00408-g003.jpg

相似文献

1
The Vascular-Immune Hypothesis of Alzheimer's Disease.阿尔茨海默病的血管 - 免疫假说
Biomedicines. 2023 Jan 30;11(2):408. doi: 10.3390/biomedicines11020408.
2
What is 'Alzheimer's disease'? The neuropathological heterogeneity of clinically defined Alzheimer's dementia.什么是“阿尔茨海默病”?临床上定义的阿尔茨海默病痴呆的神经病理学异质性。
Curr Opin Neurol. 2021 Apr 1;34(2):237-245. doi: 10.1097/WCO.0000000000000912.
3
Pathology of clinical and preclinical Alzheimer's disease.临床和临床前阿尔茨海默病的病理学。
Eur Arch Psychiatry Clin Neurosci. 2013 Nov;263 Suppl 2:S137-45. doi: 10.1007/s00406-013-0449-5.
4
The Neurovascular Unit Dysfunction in Alzheimer's Disease.阿尔茨海默病中的神经血管单元功能障碍。
Int J Mol Sci. 2021 Feb 18;22(4):2022. doi: 10.3390/ijms22042022.
5
Impact of Tau on Neurovascular Pathology in Alzheimer's Disease.Tau蛋白对阿尔茨海默病神经血管病理的影响
Front Neurol. 2021 Jan 7;11:573324. doi: 10.3389/fneur.2020.573324. eCollection 2020.
6
Alzheimer's disease.阿尔茨海默病
Subcell Biochem. 2012;65:329-52. doi: 10.1007/978-94-007-5416-4_14.
7
Recent update on the heterogeneity of the Alzheimer's disease spectrum.阿尔茨海默病谱异质性的最新研究进展。
J Neural Transm (Vienna). 2022 Jan;129(1):1-24. doi: 10.1007/s00702-021-02449-2. Epub 2021 Dec 17.
8
Neuropathology of the Alzheimer's continuum: an update.阿尔茨海默病连续体的神经病理学:最新进展
Free Neuropathol. 2020 Nov 11;1:32. doi: 10.17879/freeneuropathology-2020-3050. eCollection 2020 Jan.
9
Neuropathologic basis of in vivo cortical atrophy in the aphasic variant of Alzheimer's disease.阿尔茨海默病失语症变异型患者皮质萎缩的活体神经病理学基础。
Brain Pathol. 2020 Mar;30(2):332-344. doi: 10.1111/bpa.12783. Epub 2019 Sep 12.
10
Genome-wide association meta-analysis of neuropathologic features of Alzheimer's disease and related dementias.阿尔茨海默病及相关痴呆症神经病理特征的全基因组关联荟萃分析。
PLoS Genet. 2014 Sep 4;10(9):e1004606. doi: 10.1371/journal.pgen.1004606. eCollection 2014 Sep.

引用本文的文献

1
Optic neuritis as a link between autoimmunity and dementia risk.视神经炎作为自身免疫与痴呆风险之间的联系。
Commun Med (Lond). 2025 Aug 7;5(1):335. doi: 10.1038/s43856-025-01050-y.
2
Sex differences in sleep apnea and Alzheimer's Disease: role of cerebrovascular dysfunction.睡眠呼吸暂停与阿尔茨海默病的性别差异:脑血管功能障碍的作用。
NPJ Womens Health. 2025;3(1):27. doi: 10.1038/s44294-025-00076-w. Epub 2025 May 5.
3
Alzheimer's Disease: Exploring Pathophysiological Hypotheses and the Role of Machine Learning in Drug Discovery.

本文引用的文献

1
FDA approves Alzheimer's drug lecanemab amid safety concerns.尽管存在安全担忧,美国食品药品监督管理局仍批准了治疗阿尔茨海默病的药物lecanemab。
Nature. 2023 Jan;613(7943):227-228. doi: 10.1038/d41586-023-00030-3.
2
Amyloid β-related angiitis of the central nervous system occurring after COVID-19 vaccination: A case report.新型冠状病毒肺炎疫苗接种后发生的中枢神经系统淀粉样β相关血管炎:一例报告
World J Clin Cases. 2022 Dec 6;10(34):12617-12622. doi: 10.12998/wjcc.v10.i34.12617.
3
Lecanemab in patients with early Alzheimer's disease: detailed results on biomarker, cognitive, and clinical effects from the randomized and open-label extension of the phase 2 proof-of-concept study.
阿尔茨海默病:探索病理生理假说及机器学习在药物发现中的作用
Int J Mol Sci. 2025 Jan 24;26(3):1004. doi: 10.3390/ijms26031004.
4
Cell-specific transcriptional signatures of vascular cells in Alzheimer's disease: perspectives, pathways, and therapeutic directions.阿尔茨海默病中血管细胞的细胞特异性转录特征:观点、途径及治疗方向
Mol Neurodegener. 2025 Jan 29;20(1):12. doi: 10.1186/s13024-025-00798-0.
5
Dynamic retinal vessel analysis: flickering a light into the brain.动态视网膜血管分析:将光线投射到大脑中。
Front Aging Neurosci. 2025 Jan 6;16:1517368. doi: 10.3389/fnagi.2024.1517368. eCollection 2024.
6
Tension at the gate: sensing mechanical forces at the blood-brain barrier in health and disease.血脑屏障处的张力:健康与疾病状态下血脑屏障对机械力的感知
J Neuroinflammation. 2024 Dec 18;21(1):325. doi: 10.1186/s12974-024-03321-2.
7
Neurovascular unit, neuroinflammation and neurodegeneration markers in brain disorders.脑部疾病中的神经血管单元、神经炎症和神经退行性变标志物
Front Cell Neurosci. 2024 Oct 25;18:1491952. doi: 10.3389/fncel.2024.1491952. eCollection 2024.
8
Repurposing doxycycline for Alzheimer's treatment: Challenges from a nano-based drug delivery perspective.将强力霉素重新用于治疗阿尔茨海默病:基于纳米药物递送视角的挑战
Brain Behav Immun Health. 2024 Oct 25;42:100894. doi: 10.1016/j.bbih.2024.100894. eCollection 2024 Dec.
9
Treatment of Acute and Long-COVID, Diabetes, Myocardial Infarction, and Alzheimer's Disease: The Potential Role of a Novel Nano-Compound-The Transdermal Glutathione-Cyclodextrin Complex.急性和长期新冠、糖尿病、心肌梗死及阿尔茨海默病的治疗:一种新型纳米化合物——经皮谷胱甘肽 - 环糊精复合物的潜在作用
Antioxidants (Basel). 2024 Sep 12;13(9):1106. doi: 10.3390/antiox13091106.
10
Association of caffeine consumption with cerebrospinal fluid biomarkers in mild cognitive impairment and Alzheimer's disease: A BALTAZAR cohort study.咖啡因摄入与轻度认知障碍和阿尔茨海默病患者脑脊液生物标志物的相关性:BALTAZAR 队列研究。
Alzheimers Dement. 2024 Oct;20(10):6948-6959. doi: 10.1002/alz.14169. Epub 2024 Aug 4.
利斯卡尼单抗治疗早期阿尔茨海默病患者:来自 2 期概念验证研究随机和开放标签扩展的生物标志物、认知和临床效果的详细结果。
Alzheimers Res Ther. 2022 Dec 21;14(1):191. doi: 10.1186/s13195-022-01124-2.
4
Cerebrospinal fluid immune dysregulation during healthy brain aging and cognitive impairment.健康脑老化和认知障碍期间的脑脊液免疫失调。
Cell. 2022 Dec 22;185(26):5028-5039.e13. doi: 10.1016/j.cell.2022.11.019. Epub 2022 Dec 13.
5
Arachnoid granulations are lymphatic conduits that communicate with bone marrow and dura-arachnoid stroma.蛛网膜粒是与骨髓和硬脑膜-蛛网膜基质相通的淋巴管通道。
J Exp Med. 2023 Feb 6;220(2). doi: 10.1084/jem.20220618. Epub 2022 Dec 5.
6
Promising candidates from drug clinical trials: Implications for clinical treatment of Alzheimer's disease in China.药物临床试验中有前景的候选药物:对中国阿尔茨海默病临床治疗的启示
Front Neurol. 2022 Nov 15;13:1034243. doi: 10.3389/fneur.2022.1034243. eCollection 2022.
7
Lecanemab in Early Alzheimer's Disease.早期阿尔茨海默病中的lecanemab
N Engl J Med. 2023 Jan 5;388(1):9-21. doi: 10.1056/NEJMoa2212948. Epub 2022 Nov 29.
8
Neuropathology of the Common Forms of Dementia.常见痴呆类型的神经病理学。
Clin Geriatr Med. 2023 Feb;39(1):91-107. doi: 10.1016/j.cger.2022.07.005. Epub 2022 Oct 18.
9
Aβ and Tau Prions Causing Alzheimer's Disease.β淀粉样蛋白和 Tau 朊病毒导致阿尔茨海默病。
Methods Mol Biol. 2023;2561:293-337. doi: 10.1007/978-1-0716-2655-9_16.
10
Parenchymal border macrophages regulate the flow dynamics of the cerebrospinal fluid.实质边界巨噬细胞调节脑脊液的流动动力学。
Nature. 2022 Nov;611(7936):585-593. doi: 10.1038/s41586-022-05397-3. Epub 2022 Nov 9.